Table 1:
Demographic and medical history of LURN participants by OAB subgroup
| Control (n=67) n(%) |
OAB-dry (n=56) n(%) |
OAB-wet (n=84) n(%) |
Wet vs Dry p value |
|
|---|---|---|---|---|
|
| ||||
| Age (mean[SD]) | - | 58.4[16.1] | 56.8[15.8] | 0.95 |
|
| ||||
| Race | ||||
| American Indian/Alaskan Native | 0(0%) | 3(5%) | 1(1%) | 0.22 |
| Asian | 1(2%) | 3(5%) | 4(5%) | 0.99 |
| African-American | 9(13%) | 4(7%) | 16(19%) | 0.08 |
| Native Hawaiian/Pacific Islander | 0(0%) | 0(0%) | 1(1%) | 0.49 |
| White | 58(85%) | 46(83%) | 63(75%) | 0.31 |
| Multi-racial/Other | 0(0%) | 1(2%) | 0(0%) | NS |
|
| ||||
| BMI (kg/m2) (mean[SD]) | 28[7.1] | 30[6.7] | 31[7.9] | 0.31 |
|
| ||||
| Number of vaginal births (median [IQR]) | 0[0–2] | 1[0–2] | 2[0–2] | 0.25 |
|
| ||||
| Post-menopausal | 35(51%) | 34(61%) | 58(69%) | 0.35 |
|
| ||||
| Hormone use | 21(31%) | 10(17%) | 12(14%) | 0.72 |
|
| ||||
| Current or former smoker | 22(33%) | 23(41%) | 22(26%) | 0.09 |
|
| ||||
| Diabetes type I or II | 6(9%) | 8(15%) | 12(14%) | 0.93 |
|
| ||||
| COPD | 0(0%) | 10(18%) | 18(22%) | 0.44 |
|
| ||||
| Previous surgery | ||||
| Prior hysterectomy | 7(11%) | 18(32%) | 27(32%) | 0.96 |
| Prior surgery for LUTS | 0(0%) | 14(25%) | 14(17%) | 0.42 |
| Prior c-section | 14(21%) | 8(15%) | 11(13%) | 0.82 |
|
| ||||
| History of Pelvic pain | 1(2%) | 7(12%) | 9(11%) | 0.09 |
|
| ||||
| PVR (ml) (mean[SD]) | 29[42] | 43[48] | 47[64] | 0.73 |
|
| ||||
| Prolapse stage | - | 0.98 | ||
| Stage 0 | - | 28(50%) | 26(31%) | |
| Stage 1 | - | 13(23%) | 28(33%) | |
| Stage 2 | - | 9(16%) | 21(25%) | |
| Stage 3 | - | 2(3%) | 2(2%) | |
| Stage 4 | - | 0(0%) | 0(0%) | |
|
| ||||
| Finding of atrophy on exam | - | 12(22%) | 17(20%) | 0.85 |
|
| ||||
| Pelvic Floor Contraction Strength (Oxford Strength) (median [IQR]) | - | 2[2–4] | 2[1–3] | 0.24 |